» Articles » PMID: 15562011

Aurora B Overexpression Associates with the Thyroid Carcinoma Undifferentiated Phenotype and is Required for Thyroid Carcinoma Cell Proliferation

Abstract

Alterations in chromosome number (aneuploidy) are common in human neoplasias. Loss of mitotic regulation is believed to induce aneuploidy in cancer cells and act as a driving force during the malignant progression. The serine/theronine protein kinases of aurora family genes play a critical role in the regulation of key cell cycle processes. Aurora B mediates chromosome segregation by ensuring orientation of sister chromatids and overexpression of Aurora B in diploid human cells NHDF (normal human diploid fibroblast) induces multinuclearity. We analyzed Aurora B expression in human thyroid carcinomas. Cell lines originating from different histotypes showed an increase in Aurora B expression. Immunohistochemical analysis of archive samples showed a high expression of Aurora B in anaplastic thyroid carcinomas; conversely, Aurora B expression was not detectable in normal thyroid tissue. Real-time PCR analysis confirmed a strong expression of Aurora B in anaplastic thyroid carcinomas. The block of Aurora B expression induced by RNA interference or by using an inhibitor of Aurora kinase activity significantly reduced the growth of thyroid anaplastic carcinoma cells.

Citing Articles

AURKB affects the proliferation of clear cell renal cell carcinoma by regulating fatty acid metabolism.

Yang Y, Li D, Liu Z, Zhou K, Li W, Yang Y Discov Oncol. 2025; 16(1):91.

PMID: 39869264 PMC: 11772637. DOI: 10.1007/s12672-024-01352-y.


Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis.

Karami Fath M, Nazari A, Parsania N, Behboodi P, Ketabi S, Razmjouei P Med Oncol. 2024; 41(11):254.

PMID: 39352464 DOI: 10.1007/s12032-024-02524-0.


AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.

Li L, Jiang P, Hu W, Zou F, Li M, Rao T J Transl Med. 2024; 22(1):295.

PMID: 38515112 PMC: 10956193. DOI: 10.1186/s12967-024-05099-6.


The therapeutic potential of targeting the CHD protein family in cancer.

Zhang M, Wu K, Zhang W, Lin X, Cao Q, Zhang L Pharmacol Ther. 2024; 256:108610.

PMID: 38367868 PMC: 10942663. DOI: 10.1016/j.pharmthera.2024.108610.


Construction of a hepatocytes-related and protein kinase-related gene signature in HCC based on ScRNA-Seq analysis and machine learning algorithm.

Zhang Z, Mou L, Pu Z, Zhuang X J Physiol Biochem. 2023; 79(4):771-785.

PMID: 37458958 DOI: 10.1007/s13105-023-00973-1.